BioLargo Inc. Registration Statement Declared Effective
Ticker: BLGO · Form: EFFECT · Filed: Apr 16, 2026 · CIK: 0000880242
Sentiment: neutral
Topics: registration-statement, sec-filing, effectiveness
TL;DR
BioLargo's SEC filing is effective, they can now sell stock.
AI Summary
BioLargo, Inc. filed an EFFECT form, indicating the effectiveness of a registration statement, on April 16, 2026. The filing, with accession number 9999999995-26-001204, relates to Act 33 and File No. 333-294947. The company's mailing and business address is 14921 Chestnut St., Westminster, CA 92683.
Why It Matters
This filing signifies that BioLargo, Inc.'s securities offering registration statement has been approved by the SEC, allowing them to proceed with selling securities.
Risk Assessment
Risk Level: medium — Effectiveness of a registration statement is a procedural step, but the underlying offering's success and market conditions introduce risk.
Key Numbers
- 2026-04-16 — Filing Date (Date the filing was accepted by the SEC.)
- 2026-04-15 — Effectiveness Date (Date the registration statement became effective.)
Key Players & Entities
- BioLargo, Inc. (company) — Filer
- 9999999995-26-001204 (dollar_amount) — SEC Accession Number
- 2026-04-16 (date) — Filing Acceptance Date
- 2026-04-15 (date) — Effectiveness Date
- 333-294947 (dollar_amount) — File Number
FAQ
What type of filing is this?
This is an EFFECT filing, indicating the effectiveness of a registration statement.
When was the filing accepted by the SEC?
The filing was accepted on 2026-04-16.
What is the effectiveness date of the registration statement?
The effectiveness date is 2026-04-15.
What is BioLargo, Inc.'s CIK number?
BioLargo, Inc.'s CIK number is 0000880242.
What is the company's business address?
The business address is 14921 Chestnut St., Westminster, CA 92683.
Filing Details
This Form EFFECT (Form EFFECT) was filed with the SEC on April 16, 2026 regarding BIOLARGO, INC. (BLGO).